Alzheimer’s Disease: A Molecular Model and Implied Path to Improved Therapy by Meagan Susanne Weaver-Rosen, Philip Serwer

Get full text

Protective Effects of Colivelin Against Alzheimer's Disease in a PDAPP Mouse Model by Rong Yin, Kai Yin, ZhiQiang Guo, ZhiQiang Zhang, LiPin Chen, Li Cao, YuanMin Li, YaXuan Wei, XueFeng Fu, XiangQun Shi

Get full text

PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease by Marcus O.W. Grimm, Benjamin Hundsdörfer, Sven Grösgen, Janine Mett, Valerie C. Zimmer, Christoph P. Stahlmann, Viola J. Haupenthal, Tatjana L. Rothhaar, Johannes Lehmann, Andreas Pätzold, Eva G. Zinser, Heikki Tanila, Jie Shen, Ulrike Müller, Heike S. Grimm, Tobias Hartmann

Get full text

Impaired Functional Criticality of Human Brain during Alzheimer’s Disease Progression by Lili Jiang, Danyang Sui, Kaini Qiao, Hao-Ming Dong, Luonan Chen, Ying Han

Get full text

Reduction of Glycolysis Intermediate Concentrations in the Cerebrospinal Fluid of Alzheimer’s Disease Patients by Nick Bergau, Stephan Maul, Dan Rujescu, Andreas Simm, Andreas Simm, Alexander Navarrete Santos, Alexander Navarrete Santos

Get full text

Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy by Rosanna Squitti, Amit Pal, Mario Picozza, Abofazl Avan, Mariacarla Ventriglia, Mauro C. Rongioletti, Tjaard Hoogenraad

Get full text

Peptide Interference with APP and Tau Association: Relevance to Alzheimer’s Disease Amelioration by Ruth Maron, Gad Armony, Michael Tsoory, Meir Wilchek, Dan Frenkel, Ruth Arnon

Get full text

Golgi fragmentation – One of the earliest organelle phenotypes in Alzheimer’s disease neurons by Henriette Haukedal, Giulia I. Corsi, Giulia I. Corsi, Veerendra P. Gadekar, Veerendra P. Gadekar, Nadezhda T. Doncheva, Nadezhda T. Doncheva, Nadezhda T. Doncheva, Shekhar Kedia, Noortje de Haan, Abinaya Chandrasekaran, Pia Jensen, Pernille Schiønning, Sarah Vallin, Frederik Ravnkilde Marlet, Anna Poon, Carlota Pires, Fawzi Khoder Agha, Hans H. Wandall, Susanna Cirera, Anja Hviid Simonsen, Troels Tolstrup Nielsen, Jørgen Erik Nielsen, Poul Hyttel, Ravi Muddashetty, Blanca I. Aldana, Jan Gorodkin, Jan Gorodkin, Deepak Nair, Morten Meyer, Morten Meyer, Martin Røssel Larsen, Kristine Freude

Get full text

Regulatory miRNAs in Cardiovascular and Alzheimer’s Disease: A Focus on Copper by Anna Sacco, Fabio Martelli, Amit Pal, Claudia Saraceno, Luisa Benussi, Roberta Ghidoni, Mauro Rongioletti, Rosanna Squitti

Get full text

Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management by Sayali Dighe, Sunil Jog, Munira Momin, Sujata Sawarkar, Abdelwahab Omri

Get full text

Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients by Dominique F. Leitner, Dominique F. Leitner, Dominique F. Leitner, Evgeny Kanshin, Evgeny Kanshin, Arline Faustin, Arline Faustin, Manon Thierry, Manon Thierry, Daniel Friedman, Daniel Friedman, Sasha Devore, Sasha Devore, Beatrix Ueberheide, Beatrix Ueberheide, Beatrix Ueberheide, Orrin Devinsky, Orrin Devinsky, Thomas Wisniewski, Thomas Wisniewski, Thomas Wisniewski, Thomas Wisniewski

Get full text

Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings by Jade de Oliveira, Ewa Kucharska, Michelle Lima Garcez, Matheus Scarpatto Rodrigues, João Quevedo, Ines Moreno-Gonzalez, Josiane Budni

Get full text

Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer’s disease mouse model by Xufeng Cen, Yanying Chen, Xiaoyan Xu, Ronghai Wu, Fusheng He, Qingwei Zhao, Qiming Sun, Cong Yi, Jie Wu, Ayaz Najafov, Hongguang Xia

Get full text

Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment by Jordi Olloquequi, Miren Ettcheto, Amanda Cano, Ana Fortuna, Joana Bicker, Elena Sánchez-Lopez, Cristian Paz, Jesús Ureña, Ester Verdaguer, Carme Auladell, Antoni Camins

Get full text

Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis by Hazal Haytural, Rui Benfeitas, Sophia Schedin-Weiss, Erika Bereczki, Melinda Rezeli, Richard D. Unwin, Xusheng Wang, Eric B. Dammer, Erik C. B. Johnson, Nicholas T. Seyfried, Bengt Winblad, Betty M. Tijms, Pieter Jelle Visser, Susanne Frykman, Lars O. Tjernberg

Get full text

Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study by Pernille L. Kjeldsen, Peter Parbo, Kim V. Hansen, Joel F.A. Aanerud, Rola Ismail, Peter H. Nissen, Rikke B. Dalby, Malene F. Damholdt, Per Borghammer, David J. Brooks

Get full text

Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer’s disease by Leon C. D. Smyth, Helen C. Murray, Madison Hill, Eve van Leeuwen, Blake Highet, Nicholas J. Magon, Mahyar Osanlouy, Sophie N. Mathiesen, Bruce Mockett, Malvindar K. Singh-Bains, Vanessa K. Morris, Andrew N. Clarkson, Maurice A. Curtis, Wickliffe C. Abraham, Stephanie M. Hughes, Richard L. M. Faull, Anthony J. Kettle, Mike Dragunow, Mark B. Hampton

Get full text

Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease by Marcos J. Guerrero-Muñoz, Diana L. Castillo-Carranza, Shashirekha Krishnamurthy, Adriana A. Paulucci-Holthauzen, Urmi Sengupta, Cristian A. Lasagna-Reeves, Yembur Ahmad, George R. Jackson, Rakez Kayed

Get full text

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease by Usma Munawara, Michael Catanzaro, Weili Xu, Crystal Tan, Katsuiku Hirokawa, Nabil Bosco, David Dumoulin, Abdelouahed Khalil, Anis Larbi, Simon Lévesque, Charles Ramassamy, Annelise E. Barron, Stephen Cunnane, Pascale B. Beauregard, Jean-Pierre Bellenger, Serafim Rodrigues, Mathieu Desroches, Jacek M. Witkowski, Benoit Laurent, Eric H. Frost, Tamas Fulop

Get full text

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease by Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM

“…Dr., Ikerbasque, The Basque Foundation for Science Bilbao, Spain and BCAM - The Basque Center for Applied Mathematics, Mathematical, Computational and Experimental (MCEN) Research Group, Alameda de Mazarredo 14, Bilbao, Bizkaia, Basque-Country, 48009, SpainTel +34 946 567 842Email srodrigues@bcamath.orgAbstract: Alzheimer’s disease (AD) is the most common form of dementia and aging is the most common risk factor for developing the disease. …”
Get full text